title: Antihypertensive medications and the risk of incident type 2 diabetes: response to Taylor et al.
authors.forename: Aidar R
authors.initials: AR
authors.lastname: Gosmanov
authors.forename: Stephanie
authors.initials: S
authors.lastname: Connelly
authors.forename: James B
authors.initials: JB
authors.lastname: Lewis
authors.forename: Niyaz R
authors.initials: NR
authors.lastname: Gosmanov
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000009:adverse effects; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D012307:Risk Factors; D012737:Sex Factors
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers